The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer | MicrobiomeTrials
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-02-15Est. Completion: 2026-12-30
Enrollment target: 27 participants
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China